233 related articles for article (PubMed ID: 8263159)
1. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans.
Mastorakos G; Chrousos GP; Weber JS
J Clin Endocrinol Metab; 1993 Dec; 77(6):1690-4. PubMed ID: 8263159
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion.
Mastorakos G; Weber JS; Magiakou MA; Gunn H; Chrousos GP
J Clin Endocrinol Metab; 1994 Oct; 79(4):934-9. PubMed ID: 7962300
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 stimulates the hypothalamus-pituitary-adrenocortical axis in man.
Späth-Schwalbe E; Born J; Schrezenmeier H; Bornstein SR; Stromeyer P; Drechsler S; Fehm HL; Porzsolt F
J Clin Endocrinol Metab; 1994 Oct; 79(4):1212-4. PubMed ID: 7962296
[TBL] [Abstract][Full Text] [Related]
4. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia.
Torpy DJ; Papanicolaou DA; Lotsikas AJ; Wilder RL; Chrousos GP; Pillemer SR
Arthritis Rheum; 2000 Apr; 43(4):872-80. PubMed ID: 10765933
[TBL] [Abstract][Full Text] [Related]
5. Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic-pituitary-adrenal (HPA) axis in female rhesus monkeys.
Wilson ME; Fisher J; Brown J
Physiol Behav; 2005 Mar; 84(3):449-58. PubMed ID: 15763583
[TBL] [Abstract][Full Text] [Related]
6. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
[TBL] [Abstract][Full Text] [Related]
7. Agouti-related protein stimulates the hypothalamic-pituitary-adrenal (HPA) axis and enhances the HPA response to interleukin-1 in the primate.
Xiao E; Xia-Zhang L; Vulliémoz NR; Ferin M; Wardlaw SL
Endocrinology; 2003 May; 144(5):1736-41. PubMed ID: 12697678
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
Cutolo M; Foppiani L; Minuto F
J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis.
Beishuizen A; Thijs LG
J Endotoxin Res; 2003; 9(1):3-24. PubMed ID: 12691614
[TBL] [Abstract][Full Text] [Related]
10. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women.
Puder JJ; Freda PU; Goland RS; Wardlaw SL
J Clin Endocrinol Metab; 2001 Jun; 86(6):2403-8. PubMed ID: 11397831
[TBL] [Abstract][Full Text] [Related]
11. The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis.
Hueston CM; Deak T
Physiol Behav; 2014 Jan; 124():77-91. PubMed ID: 24184413
[TBL] [Abstract][Full Text] [Related]
12. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
Lizcano F; Salvador J
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
[TBL] [Abstract][Full Text] [Related]
13. Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency.
Murakami N; Fukata J; Usui T; Naito Y; Tominaga T; Nakai Y; Masui Y; Nakao K; Imura H
J Pharmacol Exp Ther; 1992 Mar; 260(3):1344-8. PubMed ID: 1312168
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.
Kano T; Sugihara H; Sudo M; Nagao M; Harada T; Ishizaki A; Nakajima Y; Tanimura K; Okajima F; Tamura H; Ishii S; Shibasaki T; Oikawa S
Peptides; 2010 Apr; 31(4):657-61. PubMed ID: 20045717
[TBL] [Abstract][Full Text] [Related]
15. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-adrenal function one week after a short burst of steroid therapy.
Carella MJ; Srivastava LS; Gossain VV; Rovner DR
J Clin Endocrinol Metab; 1993 May; 76(5):1188-91. PubMed ID: 8388401
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamo-pituitary-adrenal axis, glucose metabolism and TNF-α in narcolepsy.
Maurovich-Horvat E; Keckeis M; Lattová Z; Kemlink D; Wetter TC; Schuld A; Sonka K; Pollmächer T
J Sleep Res; 2014 Aug; 23(4):425-31. PubMed ID: 24650212
[TBL] [Abstract][Full Text] [Related]
18. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
[TBL] [Abstract][Full Text] [Related]
20. Adrenocorticotropic hormone and cortisol concentrations after corticotropin-releasing hormone stimulation testing in cats administered methylprednisolone.
Crager CS; Dillon AR; Kemppainen RJ; Brewer WG; Angarano DW
Am J Vet Res; 1994 May; 55(5):704-9. PubMed ID: 8067621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
